On Jan. 11, 2021, TheNew York Times posted an article about the virtues of fecal immunochemical testing relative to colonoscopy. The story, “A Colonoscopy Alternative Comes Home” [https://www.nytimes.com/ 2021/ 01/ 11/ health/ colonoscopy-health-home-testing.html] depicted colonoscopy as a comparatively risky procedure with few advantages over less invasive methods of testing for colorectal cancer. It also offered the speculation that financial factors— namely, greater reimbursement for endoscopy—was behind the general preference of gastroenterologists for colonoscopy over stool tests.
Trending
- GI 2.0: The Playbook | Industry Perspectives
- Disorders of Gut–Brain Interaction and the Rome V Process (Gastroenterology)
- Physician triage changed management in nearly 1 in 4 GI referrals (GI & Hepatology News)
- Upper GI Disorders: New Evidence May Refine Clinical Practice (Medscape)
- Pennsylvania Sues Chatbot Over Claims It Impersonates Doctors (MedCity News)
- Physician independence vanishes as corporate medicine swallows up U.S. health care (Medical Economics)
- Oshi Health Appoints Danny Krifcher as President and Chief Operating Officer (PR Newswire)
- Better onboarding may help GI practices retain APPs (GI & Hepatology News)
